Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease.
Efficacy of a motilin receptor agonist (ABT-229) for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002 Apr; 16(4):749-57.
View in:
PubMed
subject areas
Dose-Response Relationship, Drug
Dose-Response Relationship, Drug
Double-Blind Method
Double-Blind Method
Erythromycin
Erythromycin
Female
Female
Gastroesophageal Reflux
Gastroesophageal Reflux
Humans
Humans
Male
Male
Quality of Life
Quality of Life
Receptors, Gastrointestinal Hormone
Receptors, Gastrointestinal Hormone
Receptors, Neuropeptide
Receptors, Neuropeptide
Surveys and Questionnaires
Surveys and Questionnaires
Treatment Outcome
Treatment Outcome
authors with profiles
William Orr